Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, April 20, 2015

Seattle Genetics, Inc. Release: FDA Accepts Supplemental BLA And...

Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration has accepted for filing a supplemental Biologics License Application for ADCETRIS in the AETHERA setting for the post-transplant consolidation treatment of Hodgkin lymphoma patients at high risk of relapse or progression. The FDA granted Priority Review for the application and the Prescription Drug User Fee Act target action date is August 18, 2015.
http://ift.tt/1Gdk4pW

No comments:

Post a Comment

Popular Stem Cell Roundup Posts